The supply of the circuit boards needed to fix the devices is significantly constrained, preventing the company from ...
The FDA issued an early alert warning customers of potential issues with certain Resmed (NYSE:RMD) ventilator systems.
Resmed has issued a voluntary Global Medicare Device Correction / Field Safety Notice for its Astral 100 and Astral 150 ventilators built prior to October 2024. At issue: The vents may stop delivering ...
WASHINGTON - The U.S. Food and Drug Administration (FDA) on July 15 issued an early alert to notify the public of a potentially high-risk device issue with certain Resmed Astral 100 and Astral 150 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results